论文部分内容阅读
本刊讯北京颖泰嘉和生物科技股份有限公司(以下简称颖泰生物)于昨日发布了2016年度年中报告。报告期内,该公司实现营业收入19.90亿元,比上年同期下降6.53%,主要是农药市场持续低迷,市场竞争异常激烈,其主要产品销售价格持续低位运行,导致销售收入也有所减少所致;归属于挂牌公司股东的净利润为1.77亿元,比上年同期增长6.01%,主要是该公司优化生产
The newsletter Beijing Yingtai Jia and Biotechnology Co., Ltd. (hereinafter referred to Yingtai biological) yesterday released the 2016 annual report. During the reporting period, the company achieved operating income of 1.99 billion yuan, down 6.53% over the previous year, mainly due to continued downturn in pesticide market, fierce market competition, the sales of its major products continued to run low, resulting in reduced sales revenue ; Net profit attributable to shareholders of listed companies was 177 million yuan, an increase of 6.01% over the previous year, mainly due to the company to optimize production